Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01794520 · COMPLETED

Trial details

NCT number: NCT01794520
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2012-10-10
Primary completion: 2021-11-29
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.